Activators of G-protein signaling 3: a drug addiction molecular gateway.
Drug addiction is marked by continued drug-seeking behavior despite deleterious consequences and a heightened propensity to relapse not withstanding long, drug-free periods. The enduring nature of addiction has been hypothesized to arise from perturbations in intracellular signaling, gene expression, and brain circuitry induced by substance abuse. Ameliorating some of these aberrations should abate behavioral and neurochemical markers associated with an 'addiction phenotype'. This review summarizes data showing that protein expression and signaling through the nonreceptor activator of G-protein signaling 3 (AGS3) are altered by commonly abused substances in rat and in in-vitro addiction models. AGS3 structure and function are unrelated to the more broadly studied regulator of G-protein signaling family. Thus, the unique role of AGS3 is the focus of this review. Intriguingly, AGS3 protein changes persist into drug abstinence. Accordingly, studies probing the role of AGS3 in the neurochemistry of drug-seeking behavior and relapse are studied in detail. To illuminate this study, AGS3 structure, cellular localization, and function are covered so that an idealized AGS3-targeted pharmacotherapy can be proposed.
Bowers
Michael Scott
MS
Department of Psychiatry, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA. msbowers@vcu.edu
D000818:Animals; D016739:Behavior, Addictive / Q000378:metabolism*; D002352:Carrier Proteins / Q000187:drug effects / Q000378:metabolism*; D020730:Guanine Nucleotide Dissociation Inhibitors; D006801:Humans; D051381:Rats; D012008:Recurrence; D015398:Signal Transduction; D019966:Substance-Related Disorders / Q000188:drug therapy / Q000503:physiopathology*
D002352:Carrier Proteins; C525615:GPSM1 protein, human; C498913:Gpsm1 protein, rat; D020730:Guanine Nucleotide Dissociation Inhibitors